Biodiversity risks and corporate innovation: Evidence from China.
Where this comes from
- Record sourced from PubMed, PMID 41849422.
- Also identified by DOI 10.1371/journal.pone.0342348 and PMC identifier 12998866.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Whether firms adopt positive behaviors in response to biodiversity risk is a matter of public concern. In this paper, we investigate the impact of biodiversity risk exposure on corporate innovation. Based on a sample of Chinese A-share listed firms from 2007-2022, we find that biodiversity risk is significantly and positively related to corporate innovation. This promotion can be attributed to higher operating costs and enhanced analyst attention. Meanwhile, the positive impact of biodiversity risk on corporate innovation is more pronounced in firms with high investor sentiment, non-high-tech industries, and more liberalized capital markets. Additionally, the promotion of innovation by biodiversity risk is manifested more in substantive innovation. This study enriches the research on the consequences of biodiversity risk and the factors influencing firm innovation, expanding the boundaries of how environmental risk affects corporate decision-making.
Medical subject headings
- Biodiversity
- Conservation of Natural Resources
- Organizational Innovation